Safety of multiple doses of ofloxacin in healthy volunteers.

Author: BealsB S, FlorS C, SteinG E

Paper Details 
Original Abstract of the Article :
A safety profile of ofloxacin, a new fluoroquinolone antibiotic, was assessed in twelve healthy male volunteers. Ofloxacin was dosed at 400 mg twice daily over a 10-day course of treatment. This evaluation included chemistry and haematologic profiles, neurologic evaluations, ophthalmologic examinati...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/1841044

データ提供:米国国立医学図書館(NLM)

Ofloxacin: A New Fluoroquinolone with a Favorable Safety Profile

Ofloxacin, a new fluoroquinolone antibiotic, is a promising treatment option for various bacterial infections. This study assessed the safety of ofloxacin in healthy volunteers, examining its impact on various physiological parameters.

Think of this research as a careful exploration of a new desert path, where the researchers are testing the safety and effectiveness of a new drug. They are carefully monitoring the volunteers' health to determine if ofloxacin is safe and well-tolerated.

Ofloxacin: A Safe and Well-Tolerated Antibiotic

The study found that ofloxacin was safe and well-tolerated in healthy volunteers. The most common side effects were gastrointestinal, and no serious adverse events were reported.

A Promising New Antibiotic

This research provides reassurance about the safety of ofloxacin, suggesting that it may be a valuable addition to the antibiotic arsenal for treating various bacterial infections.

Dr.Camel's Conclusion

This study offers valuable insights into the safety profile of ofloxacin. It suggests that this new fluoroquinolone antibiotic has a favorable safety profile and may be a promising option for treating bacterial infections.

Date :
  1. Date Completed 1992-11-04
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

1841044

DOI: Digital Object Identifier

1841044

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.